Synlait Milk (ASX:SM1) share price on watch after FY 2020 profit decline

The Synlait Milk Ltd (ASX:SM1) share price will be on watch this morning after the release of its FY 2020 results…

| More on:
asx share price rise signified by baby with wide eyes and mouth signifying surprise

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Synlait Milk Ltd (ASX: SM1) share price will be on watch on the Monday following the release of its full year results.

How did Synlait Milk perform in FY 2020?

For the 12 months ended 31 July 2020, the dairy processor reported a 27% increase in revenue to NZ$1.3 billion.

This was driven by a 15% increase in consumer-packaged infant formula sales to 49,180 MT and a 46% lift in lactoferrin sales to 30 MT.

Margin contraction from a higher cost base led to Synlait's earnings before interest, tax, depreciation, and amortisation (EBITDA) not increasing in line with sales. It rose 13% to NZ$171.4 million in FY 2020.

Things were worse on the bottom line, with the company's net profit after tax falling 9% to NZ$75.2 million.

Resilient performance.

Synlait's Chair, Graeme Milne, commented: "Synlait's financial performance was resilient when viewed against the backdrop of COVID-19. The company remains solid and highly profitable with EBITDA growing strongly demonstrating the strength of our core infant and lactoferrin businesses."

Mr Milne notes that its profits were down in FY 2020 due to the company investing in its future growth. He appears confident these investments will create long term value for shareholders.

He explained: "Our NPAT performance did reduce reflecting investments made in new facilities and acquisitions over the past two years to achieve our growth ambitions. We are however well positioned to grow earnings off our current asset base."

The company's CEO, Leon Clement, echoed this sentiment and appears positive on the future.

Mr Clement commented: "Synlait is focused on building a sustainable, diverse and recurring earnings base that comes from multiple customers, sites, markets and categories."

"We are achieving this while balancing the needs of people, planet and profit in our decisions, and responding to changing customer demand against the backdrop of COVID-19. Our strategy to create a strong, diverse company, is more relevant than ever given the uncertain world ahead. Our team delivered a strong result in an exceptional year," he added.

Outlook.

In light of the uncertain economic environment, at this point the company is targeting a similar or slightly improved profit result in FY 2021.

A further update will be provided at Synlait's half year result in March 2021.

Elsewhere in the industry, this morning A2 Milk Company Ltd (ASX: A2M) warned of tough trading conditions in the daigou channel for infant formula sales. It is one of Synlait's largest customers.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another red day on the markets this Wednesday.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Northern Star, Pro Medicus, and Web Travel shares

How does the team at Morgans rate these popular shares? Let's find out.

Read more »

Multiracial happy young people stacking hands outside - University students hugging in college campus - Youth community concept with guys and girls standing together supporting each other.
Share Gainers

Why 4DMedical and these ASX shares are up 200%+ in just a year

These shares have made their shareholders wealthy over the past year.

Read more »

Four people on the beach leap high into the air.
Opinions

4 reasons why I think BHP shares are a must-buy for 2026

The mining giant's shares are now 20% higher than this time last year.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A few gold nullets sit on an old-fashioned gold scale, representing ASX gold shares.
Broker Notes

Up 300% since August, why this surging ASX gold stock could keep racing higher

A leading broker forecasts more strong outperformance from this rocketing ASX gold stock.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why 29Metals, Navigator Global, Praemium, and Xero shares are sinking today

These shares are having a tough time on hump day. But why?

Read more »